Ozanimod for adult patients with relapsing remitting multiple sclerosis

SMC
Record ID 32018001091
English
Authors' objectives: To assess clinical and cost effectiveness.
Details
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Scotland
MeSH Terms
  • Multiple Sclerosis, Relapsing-Remitting
  • Oxadiazoles
  • Indans
  • Sphingosine 1 Phosphate Receptor Modulators
  • Drug Therapy
Contact
Organisation Name: Scottish Medicines Consortium (SMC)
Contact Address: Delta House | 50 West Nile Street
Contact Name: Susan Downie
Contact Email: susan.downie3@nhs.scot
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.